Cargando…

CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer

CD163 is a member of the scavenger receptor cysteine-rich superfamily, and has been widely used to identify M2 type macrophage. However, the expression of CD163 in gastric cancer and its regulatory mechanism are still unclear. Here we show that CD163 is elevated in gastric cancer tissues. High expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Zhenguo, Zhang, Danhua, Gong, Baocheng, Wang, Pengliang, Liu, Funan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675630/ https://www.ncbi.nlm.nih.gov/pubmed/29152078 http://dx.doi.org/10.18632/oncotarget.20244

Ejemplares similares

Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG
por: Duan, Shijie, et al.
Publicado: (2018)

MicroRNA-28-5p inhibits the migration and invasion of gastric cancer cells by suppressing AKT phosphorylation
por: Xiao, Fangtao, et al.
Publicado: (2018)

Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivity
por: Duan, Shijie, et al.
Publicado: (2019)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI
por: Tarin, Carlos, et al.
Publicado: (2015)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer
por: Huang, Yi, et al.
Publicado: (2016)

Recent advances in inhibition of porcine reproductive and respiratory syndrome virus through targeting CD163
por: Zhang, Xiaoxiao, et al.
Publicado: (2022)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
Publicado: (2018)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
por: Huang, Xiaopei, et al.
Publicado: (2018)

Computer-aided drug design, synthesis and identification of disulfide compounds as novel and potential allosteric PAK1 inhibitors
por: Huang, Hanwei, et al.
Publicado: (2018)

STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

Stat3 as a potential therapeutic target for rheumatoid arthritis
por: Oike, Takatsugu, et al.
Publicado: (2017)

JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
por: Godoi, Mariely A., et al.
Publicado: (2023)

Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
por: Zhuang, Yan, et al.
Publicado: (2022)

Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
por: Graversen, Jonas H, et al.
Publicado: (2012)

Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019)

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
por: Nikkarinen, Anna, et al.
Publicado: (2023)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

STAT1: a novel candidate biomarker and potential therapeutic target of the recurrent aphthous stomatitis
por: Cao, Mingchen, et al.
Publicado: (2021)

STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer
por: Mohanty, Sambit K., et al.
Publicado: (2017)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Sequence variation, evolutionary constraint, and selection at the CD163 gene in pigs
por: Johnsson, Martin, et al.
Publicado: (2018)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients
por: Greco, Rosaria, et al.
Publicado: (2021)

In vivo identification of novel STAT5 target genes
por: Basham, Beth, et al.
Publicado: (2008)

Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients
por: Zhang, Na, et al.
Publicado: (2022)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer
por: Zhang, Hongzhi, et al.
Publicado: (2019)

CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease
por: Najem, Hinda, et al.
Publicado: (2021)

Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic
por: Alcolea, Verónica, et al.
Publicado: (2019)

Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target
por: Cao, Jielu, et al.
Publicado: (2022)

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
por: Gong, Xumeng, et al.
Publicado: (2023)

Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment
por: Mori, Kazumasa, et al.
Publicado: (2015)

A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells
por: Liu, Funan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i6f7udk74gnh8ecnfmr9a87243